ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $218,000 | -67.5% | 6,726 | -59.1% | 0.01% | -81.7% |
| Q1 2020 | $670,000 | +60.3% | 16,439 | +142.5% | 0.06% | +215.8% |
| Q4 2019 | $418,000 | -21.4% | 6,778 | -7.1% | 0.02% | +5.6% |
| Q3 2019 | $532,000 | +29.4% | 7,299 | -12.1% | 0.02% | +38.5% |
| Q1 2017 | $411,000 | +47.3% | 8,300 | +80.4% | 0.01% | +85.7% |
| Q4 2016 | $279,000 | -35.3% | 4,600 | -29.2% | 0.01% | -30.0% |
| Q3 2016 | $431,000 | +3.1% | 6,500 | -47.7% | 0.01% | -9.1% |
| Q1 2016 | $418,000 | -19.1% | 12,431 | +8.6% | 0.01% | -21.4% |
| Q4 2015 | $517,000 | -22.5% | 11,451 | -32.2% | 0.01% | -39.1% |
| Q3 2015 | $667,000 | +54.0% | 16,885 | +141.9% | 0.02% | +76.9% |
| Q2 2015 | $433,000 | -43.7% | 6,981 | -43.2% | 0.01% | -48.0% |
| Q1 2015 | $769,000 | -8.8% | 12,289 | -17.8% | 0.02% | -13.8% |
| Q4 2014 | $843,000 | – | 14,948 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |